{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:07:53Z","timestamp":1789207673504,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente Project L2\/30_25"],"award-info":[{"award-number":["Ricerca Corrente Project L2\/30_25"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente Project L2\/35_25"],"award-info":[{"award-number":["Ricerca Corrente Project L2\/35_25"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Projects L4\/48_25"],"award-info":[{"award-number":["Projects L4\/48_25"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-POC-2022-12375769"],"award-info":[{"award-number":["PNRR-POC-2022-12375769"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08905-5","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:44:12Z","timestamp":1788191052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry"],"prefix":"10.1186","volume":"24","author":[{"given":"Concetta","family":"Ragone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mauriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Cavalluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biancamaria","family":"Cembrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Ciotola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7167-4817","authenticated-orcid":false,"given":"Maria","family":"Tagliamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-7114","authenticated-orcid":false,"given":"Luigi","family":"Buonaguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"8905_CR1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","volume":"14","author":"AW Purcell","year":"2019","unstructured":"Purcell AW, Ramarathinam SH, Ternette N. Mass spectrometry\u2013based identification of MHC-bound peptides for immunopeptidomics. Nat Protoc. 2019;14:1687\u2013707. https:\/\/doi.org\/10.1038\/s41596-019-0133-y.","journal-title":"Nat Protoc"},{"issue":"8","key":"8905_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","volume":"3","author":"MJ Lin","year":"2022","unstructured":"Lin MJ, Svensson-Arvelund J, Lubitz GS, Marabelle A, Melero I, Brown BD, Brody JD. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022;3(8):911\u201326. https:\/\/doi.org\/10.1038\/s43018-022-00418-6.","journal-title":"Nat Cancer"},{"issue":"3","key":"8905_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","volume":"24","author":"PD Katsikis","year":"2024","unstructured":"Katsikis PD, Ishii KJ, Schliehe C. Challenges in developing personalized neoantigen cancer vaccines. Nat Rev Immunol. 2024;24(3):213\u201327. https:\/\/doi.org\/10.1038\/s41577-023-00937-y. Epub 2023 Oct 2.","journal-title":"Nat Rev Immunol"},{"key":"8905_CR4","doi-asserted-by":"publisher","first-page":"e013130","DOI":"10.1136\/jitc-2025-013130","volume":"14","author":"OJ Finn","year":"2026","unstructured":"Finn OJ. Opportunity knocking: shared tumor-associated antigen vaccines against global cancer pandemic. J Immunother Cancer. 2026;14:e013130. https:\/\/doi.org\/10.1136\/jitc-2025-013130.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"8905_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymthe.2020.12.005","volume":"29","author":"L Buonaguro","year":"2021","unstructured":"Buonaguro L, Cerullo V, Pathogens. Our Allies against Cancer? Mol Ther. 2021;29(1):10\u20132. https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.005.","journal-title":"Mol Ther"},{"issue":"1","key":"8905_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-023-01776-0","volume":"22","author":"M Tagliamonte","year":"2023","unstructured":"Tagliamonte M, Cavalluzzo B, Mauriello A, Ragone C, Buonaguro FM, Tornesello ML, Buonaguro L. Molecular mimicry and cancer vaccine development. Mol Cancer. 2023;22(1):75. https:\/\/doi.org\/10.1186\/s12943-023-01776-0.","journal-title":"Mol Cancer"},{"key":"8905_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nri3279","volume":"12","author":"A Sewell","year":"2012","unstructured":"Sewell A. Why must T cells be cross-reactive? Nat Rev Immunol. 2012;12:669\u201377. https:\/\/doi.org\/10.1038\/nri3279.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"8905_CR8","doi-asserted-by":"publisher","first-page":"e002694","DOI":"10.1136\/jitc-2021-002694","volume":"9","author":"C Ragone","year":"2021","unstructured":"Ragone C, Manolio C, Cavalluzzo B, Mauriello A, Tornesello ML, Buonaguro FM, Castiglione F, Vitagliano L, Iaccarino E, Ruvo M, Tagliamonte M, Buonaguro L. Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs). J Immunother Cancer. 2021;9(5):e002694. https:\/\/doi.org\/10.1136\/jitc-2021-002694.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"8905_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00262-024-03770-x","volume":"73","author":"JRD Pearson","year":"2024","unstructured":"Pearson JRD, Puig-Saenz C, Thomas JE, Hardowar LD, Ahmad M, Wainwright LC, McVicar AM, Brentville VA, Tinsley CJ, Pockley AG, Durrant LG, McArdle SEB. TRP-2 \/ gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer Immunol Immunother. 2024;73(9):178. https:\/\/doi.org\/10.1007\/s00262-024-03770-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"8905_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1349-7006.2006.00194.x","volume":"97","author":"T Suda","year":"2006","unstructured":"Suda T, Tsunoda T, Uchida N, Watanabe T, Hasegawa S, Satoh S, Ohgi S, Furukawa Y, Nakamura Y, Tahara H. Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray. Cancer Sci. 2006;97(5):411\u20139. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00194.x.","journal-title":"Cancer Sci"},{"issue":"1","key":"8905_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12967-022-03512-6","volume":"20","author":"C Ragone","year":"2022","unstructured":"Ragone C, Manolio C, Mauriello A, Cavalluzzo B, Buonaguro FM, Tornesello ML, Tagliamonte M, Buonaguro L. Molecular mimicry between tumor associated antigens and microbiota-derived epitopes. J Transl Med. 2022;20(1):316. https:\/\/doi.org\/10.1186\/s12967-022-03512-6.","journal-title":"J Transl Med"},{"key":"8905_CR12","doi-asserted-by":"publisher","first-page":"1398002","DOI":"10.3389\/fimmu.2024.1398002","volume":"15","author":"C Ragone","year":"2024","unstructured":"Ragone C, Mauriello A, Cavalluzzo B, Cavalcanti E, Russo L, Manolio C, Mangano S, Cembrola B, Tagliamonte M, Buonaguro L. Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization. Front Immunol. 2024;15:1398002. https:\/\/doi.org\/10.3389\/fimmu.2024.1398002.","journal-title":"Front Immunol"},{"issue":"8","key":"8905_CR13","doi-asserted-by":"publisher","first-page":"e954501","DOI":"10.4161\/21624011.2014.954501","volume":"3","author":"L Vujanovic","year":"2014","unstructured":"Vujanovic L, Shi J, Kirkwood JM, Storkus WJ, Butterfield LH. Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8+ T-cell responses. Oncoimmunology. 2014;3(8):e954501. https:\/\/doi.org\/10.4161\/21624011.2014.954501.","journal-title":"Oncoimmunology"},{"issue":"1","key":"8905_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12967-018-1662-9","volume":"16","author":"A Petrizzo","year":"2018","unstructured":"Petrizzo A, Tagliamonte M, Mauriello A, Costa V, Aprile M, Esposito R, Caporale A, Luciano A, Arra C, Tornesello ML, Buonaguro FM, Buonaguro L. Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients. J Transl Med. 2018;16(1):286. https:\/\/doi.org\/10.1186\/s12967-018-1662-9.","journal-title":"J Transl Med"},{"issue":"1","key":"8905_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/cancers14010140","volume":"14","author":"B Cavalluzzo","year":"2021","unstructured":"Cavalluzzo B, Mauriello A, Ragone C, Manolio C, Tornesello ML, Buonaguro FM, Tvingsholm SA, Hadrup SR, Tagliamonte M, Buonaguro L. Novel Molecular Targets for Hepatocellular Carcinoma. Cancers (Basel). 2021;14(1):140. https:\/\/doi.org\/10.3390\/cancers14010140.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8905_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12967-022-03681-4","volume":"20","author":"C Manolio","year":"2022","unstructured":"Manolio C, Ragone C, Cavalluzzo B, Mauriello A, Tornesello ML, Buonaguro FM, Salomone Megna A, D\u2019Alessio G, Penta R, Tagliamonte M, Buonaguro L. Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case. J Transl Med. 2022;20(1):472. https:\/\/doi.org\/10.1186\/s12967-022-03681-4.","journal-title":"J Transl Med"},{"issue":"2","key":"8905_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.184.2.647","volume":"184","author":"DJ Loftus","year":"1996","unstructured":"Loftus DJ, Castelli C, Clay TM, Squarcina P, Marincola FM, Nishimura MI, Parmiani G, Appella E, Rivoltini L. Identification of epitope mimics recognized by CTL reactive to the melanoma\/melanocyte-derived peptide MART-1(27\u201335). J Exp Med. 1996;184(2):647\u201357. https:\/\/doi.org\/10.1084\/jem.184.2.647.","journal-title":"J Exp Med"},{"issue":"5","key":"8905_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1084\/jem.190.5.705","volume":"190","author":"MJ Pittet","year":"1999","unstructured":"Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Li\u00e9nard D, Lejeune F, Fleischhauer K, Cerundolo V, Cerottini JC, Romero P. High frequencies of naive Melan-A\/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med. 1999;190(5):705\u201315. https:\/\/doi.org\/10.1084\/jem.190.5.705.","journal-title":"J Exp Med"},{"issue":"3","key":"8905_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.immuni.2021.02.014","volume":"54","author":"SH Chiou","year":"2021","unstructured":"Chiou SH, Tseng D, Reuben A, Mallajosyula V, Molina IS, Conley S, Wilhelmy J, McSween AM, Yang X, Nishimiya D, Sinha R, Nabet BY, Wang C, Shrager JB, Berry MF, Backhus L, Lui NS, Wakelee HA, Neal JW, Padda SK, Berry GJ, Delaidelli A, Sorensen PH, Sotillo E, Tran P, Benson JA, Richards R, Labanieh L, Klysz DD, Louis DM, Feldman SA, Diehn M, Weissman IL, Zhang J, Wistuba II, Futreal PA, Heymach JV, Garcia KC, Mackall CL, Davis MM. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54(3):586\u2013e6028. https:\/\/doi.org\/10.1016\/j.immuni.2021.02.014.","journal-title":"Immunity"},{"issue":"11","key":"8905_CR20","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.chom.2024.10.006","volume":"32","author":"ADG Macandog","year":"2024","unstructured":"Macandog ADG, Catozzi C, Capone M, Nabinejad A, Nanaware PP, Liu S, Vinjamuri S, Stunnenberg JA, Gali\u00e8 S, Jodice MG, Montani F, Armanini F, Cassano E, Madonna G, Mallardo D, Mazzi B, Pece S, Tagliamonte M, Vanella V, Barberis M, Ferrucci PF, Blank CU, Bouvier M, Andrews MC, Xu X, Santambrogio L, Segata N, Buonaguro L, Cocorocchio E, Ascierto PA, Manzo T, Nezi L. Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients. Cell Host Microbe. 2024;32(11):2004\u2013e20189. https:\/\/doi.org\/10.1016\/j.chom.2024.10.006.","journal-title":"Cell Host Microbe"},{"key":"8905_CR21","doi-asserted-by":"publisher","first-page":"175883592110114","DOI":"10.1177\/17588359211011455","volume":"13","author":"A Ottaiano","year":"2021","unstructured":"Ottaiano A, Scala S, D\u2019Alterio C, Trotta A, Bello A, Rea G, Picone C, Santorsola M, Petrillo A, Nasti G. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. Ther Adv Med Oncol. 2021;13:17588359211011455. https:\/\/doi.org\/10.1177\/17588359211011455.","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"8905_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/0008-5472.632.65.2","volume":"65","author":"L Rivoltini","year":"2005","unstructured":"Rivoltini L, et al. Immunogenicity without Immunoselection: A Mutant but Functional Antioxidant Enzyme Retained in a Human Metastatic Melanoma and Targeted by CD8\u2009+\u2009T Cells with a Memory Phenotype. Cancer Res. 2005;65(2):632\u201341. PMID: 15695408.).","journal-title":"Cancer Res"},{"issue":"11","key":"8905_CR23","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"CH Koh","year":"2023","unstructured":"Koh CH, Lee S, Kwak M, Kim BS, Chung Y. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med. 2023;55(11):2287\u201399. https:\/\/doi.org\/10.1038\/s12276-023-01105-x.","journal-title":"Exp Mol Med"},{"issue":"11","key":"8905_CR24","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ni1257","volume":"6","author":"FE Tynan","year":"2005","unstructured":"Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J. T cell receptor recognition of a \u2018super-bulged\u2019 major histocompatibility complex class I-bound peptide. Nat Immunol. 2005;6(11):1114\u201322. https:\/\/doi.org\/10.1038\/ni1257.","journal-title":"Nat Immunol"},{"issue":"23","key":"8905_CR25","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1073\/pnas.1004926107","volume":"107","author":"SR Burrows","year":"2010","unstructured":"Burrows SR, Chen Z, Archbold JK, Tynan FE, Beddoe T, Kjer-Nielsen L, Miles JJ, Khanna R, Moss DJ, Liu YC, Gras S, Kostenko L, Brennan RM, Clements CS, Brooks AG, Purcell AW, McCluskey J, Rossjohn J. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci U S A. 2010;107(23):10608\u201313. https:\/\/doi.org\/10.1073\/pnas.1004926107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"8905_CR26","doi-asserted-by":"publisher","first-page":"15442","DOI":"10.1074\/jbc.M112.447185","volume":"288","author":"YC Liu","year":"2013","unstructured":"Liu YC, Miles JJ, Neller MA, Gostick E, Price DA, Purcell AW, McCluskey J, Burrows SR, Rossjohn J, Gras S. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule. J Biol Chem. 2013;288(22):15442\u201354. https:\/\/doi.org\/10.1074\/jbc.M112.447185.","journal-title":"J Biol Chem"},{"issue":"3","key":"8905_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1173","volume":"6","author":"M Krogsgaard","year":"2005","unstructured":"Krogsgaard M, Davis MM. How T cells \u2018see\u2019 antigen. Nat Immunol. 2005;6(3):239\u201345. https:\/\/doi.org\/10.1038\/ni1173.","journal-title":"Nat Immunol"},{"issue":"9","key":"8905_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s0167-5699(98)01299-7","volume":"19","author":"D Mason","year":"1998","unstructured":"Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today. 1998;19(9):395\u2013404. https:\/\/doi.org\/10.1016\/s0167-5699(98)01299-7.","journal-title":"Immunol Today"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08905-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:37:12Z","timestamp":1789205832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08905-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8905"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08905-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the Institutional Ethical Committee of the Istituto Nazionale Tumori - IRCCS - \u201cFond G. Pascale\u201d \u2013 NAPOLI IT in accordance with the Declaration of Helsinki (Protocol n. 57\/22 OSS \u201cHepAnt \u2013 Tumor antigen discovery for innovative cancer immunotherapies in HCC: from benchside to bedside\u201d e subsequent amendments).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The participants have undersigned the consent to participate.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author has received consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1179"}}